The CB2 cannabinoid receptor signals apoptosis via ceramide-dependent activation of the mitochondrial intrinsic pathway
Related Experiment Video
Updated: Aug 9, 2026

Monitoring Dynamic Changes In Mitochondrial Calcium Levels During Apoptosis Using A Genetically Encoded Calcium Sensor
Published on: April 1, 2011
Blanca Herrera1, Arkaitz Carracedo, María Diez-Zaera
1Department of Biochemistry and Molecular Biology I, School of Biology, Complutense University, c/José Antonio Novais s/n, 28040 Madrid, Spain.
Abstract:
Delta9-tetrahydrocannabinol and other cannabinoids exert pro-apoptotic actions in tumor cells via the CB2 cannabinoid receptor. However, the molecular mechanism involved in this effect has remained elusive. Here we used the human leukemia cell line Jurkat-that expresses CB2 as the unique CB receptor-to investigate this mechanism. Our results show that incubation with the selective CB2 antagonist SR144528 abrogated the pro-apoptotic effect of Delta9-tetrahydrocannabinol. Cannabinoid treatment led to a CB2 receptor-dependent stimulation of ceramide biosynthesis and inhibition of this pathway prevented Delta9-tetrahydrocannabinol-induced mitochondrial hypopolarization and cytochrome c release, indicating that ceramide acts at a pre-mitochondrial level. Inhibition of ceramide synthesis de novo also prevented caspase activation and apoptosis. Caspase 8 activation-an event typically related with the extrinsic apoptotic pathway-was also evident in this model. However, activation of this protease was post-mitochondrial since (i) a pan-caspase inhibitor as well as a selective caspase 8 inhibitor were unable to prevent Delta9-tetrahydrocannabinol-induced loss of mitochondrial-membrane transmembrane potential, and (ii) cannabinoid-induced caspase 8 activation was not observed in Bcl-xL over-expressing cells. In summary, results presented here show that CB2 receptor activation signals apoptosis via a ceramide-dependent stimulation of the mitochondrial intrinsic pathway.
Insights
Delta9-tetrahydrocannabinol (THC) induces cancer cell death through the CB2 receptor. This study reveals THC triggers apoptosis via ceramide production, activating the intrinsic mitochondrial pathway.
Area of Science:
- Molecular Biology
- Cell Biology
- Pharmacology
Background:
- Cannabinoids, including Delta9-tetrahydrocannabinol (THC), exhibit anti-cancer properties by inducing apoptosis in tumor cells.
- The precise molecular mechanisms underlying cannabinoid-induced apoptosis, particularly via the CB2 receptor, remain incompletely understood.
Purpose of the Study:
- To elucidate the molecular pathway through which Delta9-tetrahydrocannabinol (THC) induces apoptosis in leukemia cells expressing the CB2 receptor.
Main Methods:
- Utilized the human leukemia cell line Jurkat, which uniquely expresses the CB2 receptor.
- Investigated the role of ceramide biosynthesis and mitochondrial pathways in THC-induced apoptosis.
- Employed CB2 antagonist SR144528, ceramide synthesis inhibitors, and caspase inhibitors to dissect the apoptotic signaling cascade.
Main Results:
- Delta9-tetrahydrocannabinol (THC) treatment stimulated ceramide biosynthesis in a CB2 receptor-dependent manner.
- Inhibition of ceramide synthesis blocked THC-induced mitochondrial dysfunction (hypopolarization, cytochrome c release) and caspase activation.
- While caspase 8 was activated, its activation was post-mitochondrial, indicating the primary apoptotic signaling occurs through the intrinsic pathway.
Conclusions:
- CB2 receptor activation by cannabinoids initiates apoptosis through a mechanism involving ceramide-dependent activation of the mitochondrial intrinsic pathway.
- Ceramide acts upstream of mitochondrial events, preceding cytochrome c release and caspase activation in THC-induced apoptosis.
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Apoptosis
Caspases
Cellular Injury V: Apoptosis and Autophagy
MAPK Signaling Cascades

